Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ketamine for the Treatment of Refractory Status Epilepticus
Sponsor: Thomas Jefferson University
Summary
This pilot feasibility study aims to examine how the timing of ketamine introduction as a third-line anti-seizure medication infusion relates to seizure cessation in patients with refractory status epilepticus (RSE).
Official title: Early Ketamine Plus Midazolam Versus Ketamine Plus Midazolam for the Treatment of Refractory Status Epilepticus
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2025-11
Completion Date
2028-07
Last Updated
2025-09-16
Healthy Volunteers
No
Conditions
Interventions
Ketamine
Timing of ketamine initiation will differ between groups (early versus late ketamine)
Midazolam
Midazolam infusion will be initiated at the same time in both groups
Locations (1)
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States